These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 30730271)

  • 1. Future perspectives of therapeutic monoclonal antibodies.
    Tsumoto K; Isozaki Y; Yagami H; Tomita M
    Immunotherapy; 2019 Feb; 11(2):119-127. PubMed ID: 30730271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are mimotope vaccines a good alternative to monoclonal antibodies?
    Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
    Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method.
    Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G
    Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging therapeutic role of antibody mixtures.
    Robak T
    Expert Opin Biol Ther; 2013 Jul; 13(7):953-8. PubMed ID: 23646883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC; Johnson PW; Glennie MJ
    Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
    Chin LT; Chu C; Chen HM; Wang DW; Liao SK
    Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg?
    Kremer L; Garcia-Sanz JA
    Front Immunol; 2018; 9():442. PubMed ID: 29556241
    [No Abstract]   [Full Text] [Related]  

  • 8. Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens.
    Boulter JM; Jakobsen BK
    Clin Exp Immunol; 2005 Dec; 142(3):454-60. PubMed ID: 16297157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies.
    Chatenoud L; Bach JF
    Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibodies as therapeutics in oncology.
    Trikha M; Yan L; Nakada MT
    Curr Opin Biotechnol; 2002 Dec; 13(6):609-14. PubMed ID: 12482522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies based on hybridoma technology.
    Yagami H; Kato H; Tsumoto K; Tomita M
    Pharm Pat Anal; 2013 Mar; 2(2):249-63. PubMed ID: 24237029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering therapeutic monoclonal antibodies.
    Liu XY; Pop LM; Vitetta ES
    Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside.
    Kuhn C; Weiner HL
    Immunotherapy; 2016 Jul; 8(8):889-906. PubMed ID: 27161438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation-specific monoclonal antibodies recognizing the native structure of G protein-coupled receptor (GPCR).
    Isozaki Y; Tsumoto K; Tomita M
    Int Immunopharmacol; 2021 Sep; 98():107872. PubMed ID: 34182241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of B-cell Epitopes of Salmonella enterica serovar Typhi Hemolysin E: Potential antibody therapeutic target.
    Chin CF; Lai JY; Choong YS; Anthony AA; Ismail A; Lim TS
    Sci Rep; 2017 May; 7(1):2176. PubMed ID: 28526816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting B cells in treatment of autoimmunity.
    Franks SE; Getahun A; Hogarth PM; Cambier JC
    Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
    Cho SF; Anderson KC; Tai YT
    Front Immunol; 2018; 9():1821. PubMed ID: 30147690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.